Defining a Mobile Health Roadmap for Cardiovascular Health and Disease

Defining a Mobile Health Roadmap for Cardiovascular Health and Disease

Zubin J. Eapen, MD, MHS, Mintu P. Turakhia, MD, MAS, Michael V. McConnell, MD, MSEE, Garth Graham, MD, MPH, Patrick Dunn, PhD, Colby Tiner, MA, Carlo Rich, BA, Robert A. Harrington, MD, Eric D. Peterson, MD, MPH, and Patrick Wayte, MBA

The evolution of mHealth is still in the beginning stages, but it is a burgeoning field that represents the promising convergence of health care and mobile technologies. To have a substantial impact on patients’ lives, developers must work closely with patients, providers, and payers. Through such collaborations, developers can understand the pressing problems in contemporary health care early in the design process. These collaborations will allow developers to solve meaningful problems rather than search for problems that legitimize “solutions” they have already developed. Furthermore, these collaborations will enable developers to better integrate their products with care delivery systems and providers on which patients continue to rely.

Conversely, patients, providers, and payers must help developers demonstrate the value of mHealth interventions. Evaluation of mHealth products must generate early evidence at a pace that matches the business and software life cycles governing the development of mHealth companies and their products. At the same time, patients, providers, and payers share the responsibility for conducting longer term, outcomes‐oriented studies that will produce long‐term safety and effectiveness evidence, which is needed for broad‐scale adoption of mHealth products. In the spirit of the inaugural AHA Health Tech Forum in 2014, future conferences are needed to bring together multidisciplinary groups from both the health care and technology fields. These meetings will help identify valuable clinical opportunities for mHealth, create guidelines and frameworks to promote success, and design evaluations that will uncover safe and effective solutions for patients.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015362/

Photo by rawpixel on Unsplash

mHealth versus face-to-face: study protocol for a randomized trial to test a gender-focused intervention for young African American women at risk for HIV in North Carolina.

Use of Mobile Devices to Measure Outcomes in Clinical Research, 2010-2016: A Systematic Literature Review.

Use of Mobile Devices to Measure Outcomes in Clinical Research, 2010-2016: A Systematic Literature Review.